Neuraxpharm strengthens its presence in Poland

25 February 2020 21:22

Neuraxpharm Group, a leading European pharmaceutical company specializing in the treatment of central nervous system (CNS) disorders, takes over the Glenmark CNS department in Poland.

This article is for subscribers

Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.

Or try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.

Already a subscriber? Sign in · No account? Join now

cns glenmark jacek sawicki neuraxpharm poland

Neuraxpharm strengthens its presence in Poland

More from Business All

88.3% of Poles choose products from promotional flyers when shopping

Poland prepares major highway upgrades as congestion grows

DataWalk secures U.S. patent protection for AI technology